GENOMEVISION
DEAD

Serial Number

76303948

Owner

Genome Therapeutics Corporation

Attorney

Fred W. Hathaway

Filing Date

Aug 24, 2001

Add to watchlist:

No watchlists yet
View on USPTO

GENOMEVISION Trademark

Serial Number: 76303948

GENOMEVISION is a trademark filed by Genome Therapeutics Corporation on August 24, 2001. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genome Therapeutics Corporation (22 trademarks)

100 Beaver Street
Waltham, MA 023548425

Entity Type: 03

Trademark Details

Filing Date

August 24, 2001

Registration Date

Not Registered

Goods & Services

Computer software, featuring a database used for genetic or protein analysis; computer hardware and computer peripherals; DNA micro array chips; scientific instruments, namely, DNA sequencers, PCR machines, clone picking robots, DNA preparation used in the preparation and separation of DNA sequences

Pharmaceuticals, namely, pharmaceutical compounds, therapeutic agents, and biotechnologic substances incorporating the results of genomic research, namely, drugs and anti-infective agents for use in combating resistant infectious diseases for human, veterinary and agricultural applications; reagents, namely, diagnostic reagents for clinical or medical laboratory use

Biotechnology research and development services in the field of genome research, namely, genetic sequencing; genomic library sequencing services; library construction services; library screening services; single nucleotide polymorphorisms (SNP) detection and screening services, namely, performing functional assays of genes, sequencing genes, identifying and characterizing genes; micro array services, namely, gene sequencing typing and chemical compound screening and gene expression micro array image analysis; high throughput screening services; bioninformatic services, namely, protein identification, characterization and analysis in the field of biomedical research; genomic assembly and finishing services; gene mapping and fingerprinting services; amplification services, namely, gene cloning identification services; biotechnological research and development services, namely, drug target identification and characterization; medical and scientific research, namely, conducting clinical trails

Filing History

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 9, 2004 ABN2
NON-FINAL ACTION MAILED
Jun 9, 2003 CNRT
LETTER OF SUSPENSION MAILED
May 10, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2002 CRFA
NON-FINAL ACTION MAILED
Oct 1, 2001 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2001 DOCK
ASSIGNED TO EXAMINER
Sep 25, 2001 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2001 CRFA